HOME >> MEDICINE >> NEWS
Mouse studies reveal immune mechanism involved in bone loss caused by estrogen deficiency

ATLANTA- Scientists have uncovered in mice a key mechanism of the immune system involved in the bone loss that results from estrogen deficiency. If confirmed in human studies, the findings would demonstrate that postmenopausal osteoporosis is the result of an inappropriate immune response triggered by estrogen deficiency. The research also could help explain why estrogen deficiency appears to exacerbate autoimmune diseases, such as rheumatoid arthritis.

Results of the research will be published in the online edition of the Proceedings of the National Academy of Sciences the week of August 4. The study's senior author was Roberto Pacifici, MD, professor of medicine and director of the Division of Endocrinology at Emory University School of Medicine. Lead author was Simone Cenci, MD, now at the San Raffaele Scientific Institute in Milan, Italy. Other authors included Gianluca Toraldo and Oscar Sierra from Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, and M. Neale Weitzman, Cristiana Roggia and Wei Ping Qian from Emory School of Medicine.

Scientists already had discovered that bone loss caused by estrogen deficiency results from the overexpansion of T cells in the immune system. Immune T cells are known to produce a protein called tumor necrosis factor (TNF) that increases the formation of osteoclasts in rodents and humans cells that help cause the absorption and removal of bone. T cell proliferation is typically caused by the activation of T cells, but until now scientists have not understood exactly why and how estrogen deficiency causes the T cells to become activated. In order to model postmenopausal estrogen deficiency, the scientists removed the ovaries from mice, then studied the mouse T cells in culture. They confirmed that T cell activation was jump started by the immune regulatory protein interferon gamma (IFN-g), which in turn stimulated a protein called class II transactivator (CIITA). They foun
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
4-Aug-2003


Page: 1 2

Related medicine news :

1. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
2. Mouse gene shows new mechanism behind cardiac infarction in man
3. Mouse model gives insight to human hair loss
4. Mouse study: Signal overload in Alzheimer brains
5. Mouse shows how Rituximab removes human B cells
6. Mouse study could aid vaccine designers
7. Mouse model mimics real-world plague infection
8. Mouse antibodies thwart SARS virus
9. Mouse model of neuromuscular disease identifies key player in motor neuron death
10. Mouse study gives new view of anthrax toxin
11. Mouse provides clues about chronic pain

Post Your Comments:
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... be at increased risk of suffering depression after giving ... hope they can use the findings to develop a ... are vulnerable to postpartum depression, which affects around 15 ... the May 21 issue of the journal Molecular ...
(Date:5/21/2013)... 2013 Pathways Home Health, Hospice ... to remember and honor a loved one in the ... Service, Sunday, June 2, 2013, 3-4 pm at Skylawn ... Mateo, CA 94402. , The Pathways Hospice Evening of ... program with music, readings and support. Open to the ...
(Date:5/21/2013)... patients are significantly more likely than their normal-weight ... practice that disrupts continuity of care and leads ... research suggests. , The practice of "doctor shopping" ... negative experiences with the health care system, whether ... weight loss advice by providers, or improperly sized ...
(Date:5/21/2013)... 2013 STAR (Sensory Therapies And ... with sensory challenges and the Sensory Processing Disorder ... and advocacy of Sensory Processing Disorder present Stumbling Blocks ... Improve Quality of Life, a two-hour lecture presented by ... , Learn a method that can aid in ...
(Date:5/21/2013)... Diehard soccer fans will definitely want to ... the game between Manchester City and Chelsea FC ... These two teams are highly decorated in the English Premiere ... to the Busch Stadium, home of the St. Louis Cardinals, ... time that a professional sporting event and non-baseball game will ...
Breaking Medicine News(10 mins):Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3Health News:Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California 2Health News:'Doctor shopping' by obese patients negatively affects health 2Health News:'Doctor shopping' by obese patients negatively affects health 3Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 3Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2
(Date:5/21/2013)... UNION CITY, Calif. , May 21, 2013 /PRNewswire/ ... manufacturing point-of-care blood analysis systems, announced today that ... will present at the Stifel Annual Dental & Veterinary ... ET. The conference will be held at Le Parker ... . About Abaxis Abaxis develops, ...
(Date:5/21/2013)...  BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC ... stem cell based therapies for various personal applications, announced ... and CEO, will be presenting at the Marcum MicroCap ... on Thursday, May 30, 2013 at the Grand Hyatt ... York City.  Mr. Weinreb,s presentation will take place at ...
(Date:5/21/2013)... SAN DIEGO , May 21, 2013 /PRNewswire/ ... from a secondary analysis of its double-blind, randomized, ... CERE-120 is a gene therapy product designed to ... This exploratory analysis identified a more robust response ... years prior to treatment relative to those diagnosed ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5
Cached News: